Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa Daily Journal.
Press releases published on August 19, 2025

Grand Lakes e VWCO promovem cursos de formação para clientes e colaboradores em Angola
A iniciativa visa promover a atualização interna e para os profissionais que operam autocarros e camiões no país SãO PAULO, SãO PAULO, BRAZIL, August 19, 2025 /EINPresswire.com/ -- A Grand Lakes, representante oficial da Volkswagen Caminhões e Ônibus ( …

Boomitra Expands Global Soil Carbon Leadership with East Africa Grassland Project Registration
With five projects now registered across Africa, Asia, and the Americas, Boomitra continues to scale inclusive, technology-powered carbon removal SAN MATEO, CA, UNITED STATES, August 19, 2025 /EINPresswire.com/ -- Boomitra, a leading soil carbon project …

Business Directive Contract Services Selected for Top Global Business of the Year in Workforce Solutions by IAOTB
Business Directive Contract Services will be honored at the International Association of Top Businesses awards gala NEW YORK, NY, UNITED STATES, August 19, 2025 /EINPresswire.com/ -- Business Directive Contract Services was selected for Top Global …

Outsourced CFO announces FundRaise Conference to help South African founders close capital in 2025
One-night forum with founders, investors, and finance experts on 28 August 2025, Wesgro Auditorium, Cape Town. Sponsored by Business Partners. CAPE TOWN, SOUTH AFRICA, August 19, 2025 /EINPresswire.com/ -- Outsourced CFO (OCFO), in conjunction with …

NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar
EMERYVILLE, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces it has entered into a $6 million securities purchase agreement with private investor David E. Lazar for the …

Atico Reports Consolidated Financial Results for Second Quarter of 2025
(All amounts expressed in US dollars, unless otherwise stated) VANCOUVER, British Columbia, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Atico Mining Corporation (the “Company” or “Atico”) (TSX.V: ATY | OTC: ATCMF) today announced its financial results for the three …

Celldex Reports Results from Phase 2 Study of Barzolvolimab in Eosinophilic Esophagitis (EoE)
Study met primary endpoint demonstrating barzolvolimab’s ability to potently deplete mast cells in the gastrointestinal tract Profound mast cell depletion did not result in improved clinical outcomes providing direct evidence that mast cells are not a …

Ligand to Participate in September Investor Conferences
JUPITER, Fla., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief Financial Officer Tavo Espinoza will participate in the following upcoming investor …

BitMobile and Twytch Partner to Empower South African Drivers Through Blockchain Innovation, VR Training, and Phēnix X
JOHANNESBURG, SOUTH AFRICA, August 19, 2025 /EINPresswire.com/ -- BitMobile and Twytch Announce Groundbreaking Partnership to Empower South African Drivers Through Blockchain, VR Training, and the Phēnix X Mobile Revolution BitMobile and Twytch Power …

China Top All-In-One Service Manufacturer for Stone Processing Machine Showcased by ShuiNan Machinery at BATIMATEC
QUANZHOU, FUJIAN, CHINA, August 19, 2025 /EINPresswire.com/ -- The construction industry faces a fundamental challenge: finding comprehensive Stone Processing Equipment solutions that combine cutting-edge technology, reliable manufacturing, and complete …

24/7 Market News: LIXTE Biotechnology Spotlight- Revisiting the “Too Much of a Good Thing” Strategy for LB-100
DENVER, Aug. 19, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, revisits the LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage …

Silo Pharma’s PTSD Candidate SPC-15 Achieves Positive Safety Milestone, Paving Way for Accelerated Clinical Trials Under 505(b)(2) Pathway
SPC-15’s intranasal spray formulation meets safety standards for clinical trial development SARASOTA, FL, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and …

Inhibikase Therapeutics Strengthens Leadership Team with Appointment of Timothy Pigot as Chief Commercial and Strategy Officer
BOSTON and ATLANTA, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing therapeutics to modify the course of pulmonary arterial hypertension (“PAH”), …

Ajax Therapeutics Appoints David Waller, PhD, as Senior Vice President and Head of CMC
NEW YORK and CAMBRIDGE, Mass., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Ajax Therapeutics, Inc., a biopharmaceutical company developing next generation Janus Kinase (JAK) inhibitors for patients with myeloproliferative neoplasms, today announced the appointment …

Milestone® Pharmaceuticals to Present at Upcoming Conferences
MONTREAL and CHARLOTTE, N.C., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced President and CEO, Joe Oliveto, will participate in one-on-one meetings at the Wells Fargo Healthcare Conference, to take place …

ALX Oncology Doses First Patient in Phase 1 Dose Escalation Trial Evaluating ADC ALX2004 for the Treatment of EGFR-Expressing Solid Tumors
- A potential best- and first-in-class antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors, ALX2004 is uniquely designed with every component optimized to maximize the therapeutic window -First-in-human trial of ALX2004 builds …

Midland Commences an Exploration Program for Copper-Gold-Molybdenum-Silver Occurrences on the Saruman Project
MONTREAL, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Midland Exploration Inc. (“Midland”) (TSX-V: MD) is pleased to report the start of an exploration program to follow up on the 2024 copper-gold-molybdenum-silver (Cu-Au-Mo-Ag) occurrences identified on its Saruman …

Midland débute un programme d’exploration pour les minéralisations en cuivre-or-molybdène-argent sur le projet Saruman
MONTRÉAL, 19 août 2025 (GLOBE NEWSWIRE) -- Exploration Midland inc. (« Midland ») (TSX-V : MD) a le plaisir d’annoncer le commencement d’un programme d’exploration pour faire un suivi sur les minéralisations en cuivre-or-molybdène-argent (Cu-Au-Mo-Ag) …

Altimmune Announces FDA Fast Track Designation for Pemvidutide in Alcohol Use Disorder (AUD)
Pemvidutide is the only drug currently granted Fast Track Designation in AUD RECLAIM, a Phase 2 trial of pemvidutide in AUD, is currently enrolling GAITHERSBURG, Md., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage …

Apollo Silver Congratulates Equinox Gold on FAST-41 Permitting
VANCOUVER, British Columbia, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Apollo Silver Corp. (“Apollo” or the “Company”) (TSX.V:APGO, OTCQB:APGOF, Frankfurt:6ZF0) congratulates Equinox Gold Corp. (TSX: EQX) (NYSE American: EQX) on the recent acceptance of its Castle …